Radiomics combined with clinical characteristics predicted the progression-free survival time in first-line targeted therapy for advanced non-small cell lung cancer with EGFR mutation

Zhu, JM; Sun, L; Wang, LJ; Zhou, TC; Yuan, YW; Zhen, X; Liao, ZW

Liao, ZW (通讯作者)，Guangzhou Med Univ, Dept Radiat Oncol, Affiliated Canc Hosp & Inst, Guangzhou 510095, Peoples R China.;Zhen, X (通讯作者)，Southern Med Univ, Sch Biomed Engn, Guangzhou 510515, Guangdong, Peoples R China.

BMC RESEARCH NOTES, 2022; 15 (1):

Abstract

Objective This study was to explore the most appropriate radiomics modeling method to predict the progression-free survival of EGFR-TKI treatment in a......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索